The last few years have been financially devastating for the hospital industry. COVID-19 and its variants have plunged the industry into financial chaos, with long-lasting impact on healthcare focused on, but far beyond, mere finances.
The CFA Perspective
A Cardiovascular Consulting Blog from CFA
John W. Meyer, LFACHE, and Charles W. Franc
In the continuing debate linking procedural volume and quality outcomes, recent published research on Transcatheter Aortic Valve Replacement (TAVR) dispersion, center proliferation, volumes and quality outcomes has brought this thorny issue to the forefront.
This is an incredibly timely and probably inevitable situation. West Des Moines, Iowa-based UnityPoint Health sued to block a large physician group, the Iowa Clinic, from opening two cardiac cath labs in its ambulatory surgery center (ASC).
Service-line consolidation has always been a challenge – theoretically feasible, strategically supportable, even desirable (particularly from a health system perspective), yet fraught with practical and political roadblocks.
Periodic News Update and Implications
Periodically, CFA will highlight a few significant news articles on cardiovascular topics -- clinical or organizational. Reprinted below are four news items we found interesting and worthy to highlight.
Occasionally, CFA will highlight a few significant news articles on cardiovascular topics -- clinical or organizational. Reprinted below are four interesting news items we feel worthy to highlight.
Hospitals with small to medium-sized cardiac valve surgery programs need to know that the era of TAVR for most or all aortic valve replacement cases (AVR) – regardless of overall risk category – is moving ever closer to reality.
Two recent developments are important for those hospitals monitoring Transcatheter Aortic Valve Replacement (TAVR) developments.
CFA has written extensively on the challenges facing the low-volume cardiac surgery program.